The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Over 100 million Indians are living with type 2 diabetes and its complexities in India,' said Eric Mansion from Sanofi.

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...

The US drug regulator has completed a pre-approval inspection at Emcure’s Ahmedabad oncology facility without issuing a Form ...

The Inter-Ministerial Group is expected to examine the share purchase agreement (SPA) for IDBI Bank, after which it will be ...

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

Shares of firms like TCS, Akzo Nobel, Emcure Pharma, Adani Ent, Tata Technologies, and others will be in focus on Thursday's ...

Bain Capital divested a 2.4% stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction, reducing its holding to 6.31%. Emcure Pharma share price fell.